Analyst Consensus ?
ConsensusBuy51 ratings
Bullish2854.9%
Neutral2141.2%
Bearish23.9%
FN2 Earnings Intelligence
Fifth Third Bancorp analyst ratings
Fifth Third Bancorp (FITB) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$56.57Current
$4.5Low
$50.7Average
$67High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 21, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 20, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jul 20, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 20, 2026 |
| UBS | Buy | Buy | Maintain | Jul 7, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 6, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 29, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jun 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Jun 8, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 20, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Mar 30, 2026 |
| TD Cowen | Buy | Buy | Maintain | Feb 3, 2026 |
| Stephens & Co. | Overweight | Equal Weight | Upgrade | Oct 14, 2025 |
| Argus Research | Buy | Buy | Maintain | Jul 22, 2024 |
| Jefferies | Buy | Buy | Maintain | Jul 3, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | May 31, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 18, 2023 |
| Wedbush | Outperform | Outperform | Maintain | Jul 21, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Sep 12, 2022 |
| CFRA | Buy | Buy | Maintain | Apr 22, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| Odeon Capital | Hold | Hold | Maintain | Dec 6, 2019 |
| Raymond James | Outperform | Outperform | Maintain | Oct 23, 2019 |
| Bank of America | Buy | Buy | Maintain | Oct 23, 2019 |
| BMO Capital | Market Perform | Market Perform | Maintain | Apr 25, 2019 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Apr 4, 2019 |
| Argus | Buy | Buy | Maintain | Jun 14, 2018 |
| Macquarie | Underperform | Neutral | Downgrade | Nov 17, 2017 |
| Compass Point | Buy | Neutral | Upgrade | Mar 29, 2017 |
| Hilliard Lyons | Neutral | Underperform | Upgrade | Jan 25, 2017 |
| Bernstein | Market Perform | Outperform | Downgrade | Nov 16, 2016 |
| CLSA | Outperform | Outperform | Maintain | Sep 23, 2016 |
| Oppenheimer | Perform | Outperform | Downgrade | Jul 6, 2016 |
| Susquehanna | Neutral | Positive | Downgrade | Jun 7, 2016 |
| Sterne Agee CRT | Neutral | Buy | Downgrade | Apr 6, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Apr 6, 2016 |
| Credit Suisse | Underperform | Underperform | Maintain | Mar 10, 2016 |
| PiperJaffray | Neutral | Neutral | Maintain | Nov 23, 2015 |
| Guggenheim | Neutral | Buy | Downgrade | Oct 21, 2015 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Jun 29, 2015 |
| FBR Capital | Market Perform | Outperform | Downgrade | Jan 22, 2015 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Dec 16, 2013 |
| Rafferty Capital | Hold | Buy | Downgrade | Nov 6, 2013 |
| Rafferty | Hold | Buy | Downgrade | Nov 6, 2013 |
| ISI Group | Buy | Buy | Maintain | Oct 7, 2013 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Feb 11, 2013 |
| Stifel | Hold | Buy | Downgrade | Feb 11, 2013 |
| Miller Tabak | Strong Buy | Strong Buy | Maintain | Aug 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $56.57. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| D.A. Davidson | Analyst unavailable | $65 | $57.96 | +14.9% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $62 | $58.01 | +9.6% | Jul 20, 2026 |
| UBS | Erika Najarian | $65 | $58.27 | +14.9% | Jul 7, 2026 |
| Evercore ISI | Analyst unavailable | $60 | $57.72 | +6.1% | Jul 6, 2026 |
| Wells Fargo | Analyst unavailable | $67 | $57.16 | +18.4% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $58 | $52.01 | +2.5% | Jun 8, 2026 |
| Truist Financial | Analyst unavailable | $57 | $51.05 | +0.8% | Apr 21, 2026 |
| Evercore ISI | Analyst unavailable | $53 | $51.68 | -6.3% | Apr 21, 2026 |
| Barclays | Jason Goldberg | $63 | $50.34 | +11.4% | Apr 20, 2026 |
| Evercore ISI | Analyst unavailable | $57 | $53.48 | +0.8% | Feb 5, 2026 |
| UBS | Erika Najarian | $59 | $54.57 | +4.3% | Feb 4, 2026 |
| Truist Financial | Analyst unavailable | $60 | $50.23 | +6.1% | Jan 26, 2026 |
| D.A. Davidson | Peter Winter | $58 | $50.19 | +2.5% | Jan 26, 2026 |
| RBC Capital | Analyst unavailable | $57 | $51.62 | +0.8% | Jan 21, 2026 |
| Wolfe Research | Analyst unavailable | $55 | $49.1 | -2.8% | Jan 7, 2026 |
| Evercore ISI | John Pancari | $52 | $49.46 | -8.1% | Jan 6, 2026 |
| UBS | Analyst unavailable | $57 | $48.62 | +0.8% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $61 | $47.71 | +7.8% | Jan 5, 2026 |
| Truist Financial | Brian Foran | $55 | $48.1 | -2.8% | Dec 22, 2025 |
| Piper Sandler | Analyst unavailable | $50 | $45.17 | -11.6% | Dec 10, 2025 |
| Stephens | Analyst unavailable | $52 | $42.2 | -8.1% | Oct 14, 2025 |
| D.A. Davidson | Analyst unavailable | $52 | $44.03 | -8.1% | Oct 8, 2025 |
| UBS | Analyst unavailable | $45 | $43.67 | -20.5% | Oct 7, 2025 |
| Morgan Stanley | Manan Gosalia | $60 | $43.79 | +6.1% | Oct 7, 2025 |
| Evercore ISI | Analyst unavailable | $49 | $45.4 | -13.4% | Sep 30, 2025 |
| Morgan Stanley | Manan Gosalia | $56 | $45.43 | -1.0% | Sep 29, 2025 |
| D.A. Davidson | Peter Winter | $47 | $39.58 | -16.9% | Jun 9, 2025 |
| D.A. Davidson | Peter Winter | $46 | $43.37 | -18.7% | Oct 21, 2024 |
| Citigroup | Keith Horowitz | $43 | $44.67 | -24.0% | Oct 21, 2024 |
| Piper Sandler | Scott Siefers | $48 | $41.76 | -15.1% | Oct 3, 2024 |
| Stephens | Terry McEvoy | $42 | $39.8 | -25.8% | Sep 11, 2024 |
| Piper Sandler | Scott Siefers | $45 | $42.34 | -20.5% | Sep 3, 2024 |
| Argus Research | Stephen Biggar | $46 | $40.42 | -18.7% | Jul 22, 2024 |
| RBC Capital | Gerard Cassidy | $43 | $40.99 | -24.0% | Jul 22, 2024 |
| D.A. Davidson | Peter Winter | $42 | $40.99 | -25.8% | Jul 22, 2024 |
| Wells Fargo | Mike Mayo | $42 | $35.28 | -25.8% | Jun 12, 2024 |
| Wolfe Research | Bill Carcache | $43 | $36.75 | -24.0% | May 31, 2024 |
| UBS | Erika Najarian | $39 | $36.05 | -31.1% | Apr 4, 2024 |
| Robert W. Baird | David George | $32 | $37.21 | -43.4% | Apr 1, 2024 |
| Stephens | Terry McEvoy | $41 | $35.43 | -27.5% | Mar 19, 2024 |
| Raymond James | David Long | $4.5 | $51.41 | -92.0% | Jan 19, 2024 |
| Barclays | Analyst unavailable | $47 | $32.81 | -16.9% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $36 | $31.94 | -36.4% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $37 | $33.28 | -34.6% | Dec 5, 2022 |
| Morgan Stanley | Analyst unavailable | $43 | $33.96 | -24.0% | Jul 12, 2022 |
| UBS | Erika Najarian | $56 | $48.88 | -1.0% | Jan 12, 2022 |
| Barclays | Jason Goldberg | $53 | $44.38 | -6.3% | Jan 3, 2022 |
| Argus Research | Stephen Biggar | $49 | $44.98 | -13.4% | Oct 20, 2021 |
| Stephens | Terry McEvoy | $48 | $44.98 | -15.1% | Oct 20, 2021 |
| KBW | David Konrad | $42 | $36.57 | -25.8% | Jul 6, 2021 |
Track every rating change on FITB the moment it posts. Free to start.
Start free